Related Experiment Video
Updated: May 7, 2026

Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens
Published on: December 9, 2022
Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironment
Kush Lohani1, Shreya Shetty, Poonam Sharma
1Department of Surgery, Creighton University Medical Center, Omaha, NE, USA.
Background:
Pseudomyxoma peritonei (PMP), a peritoneal mucinous neoplasm of appendiceal origin, is associated with inflammation and fibrosis, which is central to its biology. The significance of the microenvironment in PMP has not been well characterized.
Methods:
Immunoassays were used to measure cytokines and C-reactive protein (CRP). Forty-two cytokines were initially measured in 23 PMP ascites and 10 PMP peritoneal washings. On the basis of these results, matching serum and ascites samples were analyzed for ten relevant cytokines (n = 32) and CRP (n = 28). Immunohistochemistry was performed on formalin-fixed tissue sections. Statistical analysis was by Wilcoxon signed rank test, Mann-Whitney U-test, and bivariate analysis.
Results:
Serum CRP was elevated in PMP and correlated to CRP level in ascites. Interleukin (IL)-6, IL-8 (CXCL8), interferon gamma-induced protein 10 (IP-10), (CXCL10), monocyte chemotactic protein (MCP)-1 (CCL2), and macrophage inflammatory protein (MIP)-1α (CCL3) levels were grossly elevated in ascites but did not correlate with serum levels. Cytokines normally associated with infection or tissue injury (e.g., IL-1, IL-2, interferon gamma) were not elevated. Immunohistochemistry localized IL-6 to stroma, IP-10, and MCP-1 to tumor cells and IL-8 to adipose tissue. There were complex interactions among cytokines. IL-6, in particular, had many significant correlations in ascites. Serum IL-8, MIP-1β, and CRP were higher in PMP compared to controls.
Conclusions:
The pattern of cytokines in PMP is distinct from infection- or injury-associated inflammation. The results support peritoneal synthesis for cytokines. CRP, IL-8, and MIP-1β are potential serum markers for PMP. IL-6 appears to play a central role in PMP biology. This study provides new details about PMP tumor biology and identifies possible therapeutic targets.
Insights
Pseudomyxoma peritonei (PMP) involves distinct inflammation patterns. Elevated serum C-reactive protein (CRP), interleukin-8 (IL-8), and macrophage inflammatory protein-1 beta (MIP-1β) may serve as PMP biomarkers, with IL-6 central to PMP biology.
Area of Science:
- Oncology
- Immunology
- Gastroenterology
Background:
- Pseudomyxoma peritonei (PMP) is a rare appendiceal neoplasm characterized by peritoneal mucinous carcinomatosis.
- Inflammation and fibrosis are integral to PMP biology, but the role of the tumor microenvironment remains underexplored.
Purpose of the Study:
- To characterize the cytokine and C-reactive protein (CRP) profiles in PMP.
- To investigate the relationship between serum and ascites levels of these markers.
- To identify potential serum biomarkers and therapeutic targets for PMP.
Main Methods:
- Immunoassays were used to quantify 42 cytokines and CRP in ascites, peritoneal washings, and serum samples from PMP patients.
- Immunohistochemistry was employed to localize cytokine expression within tumor tissues.
- Statistical analyses included Wilcoxon signed rank test, Mann-Whitney U-test, and bivariate analysis.
Main Results:
- Serum CRP levels were elevated in PMP patients and correlated with ascites CRP.
- Ascites showed significantly elevated levels of interleukin-6 (IL-6), IL-8, IP-10, MCP-1, and MIP-1α, but these did not correlate with serum levels.
- IL-6 was localized to the stroma, IP-10 and MCP-1 to tumor cells, and IL-8 to adipose tissue, indicating specific cellular sources.
Conclusions:
- The PMP inflammatory cytokine profile differs from infection or injury-associated inflammation, suggesting peritoneal synthesis.
- Serum CRP, IL-8, and MIP-1β are identified as potential diagnostic markers for PMP.
- IL-6 plays a critical role in PMP pathogenesis, presenting a potential therapeutic target.
More Related Videos
07:20Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
Published on: December 21, 2012
11:34Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice
Published on: February 18, 2017
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Chronic Inflammation: Introduction
Pericarditis I: Introduction